Skip to main content

Steven Taylor, Sjögren’s Foundation CEO, was chosen to speak at Pharma & Patient USA (Dec 1-4, Virtual) as part of a panel exploring patients as partners in developing patient-centric clinical trial design.  Taylor is excited to share the success of the Foundation in ensuring Sjögren’s patients are always represented during critical discussions on clinical trial design.  

Click here to view the full Pharma & Patient USA 2020 Agenda

Click here to learn more about Clinical Trials & Sjögren’s 

Pharma & Patient Agenda